about
Effects of oral consumption of the green tea polyphenol EGCG in a murine model for human Sjogren's syndrome, an autoimmune diseaseSicca complex among Egyptian patients with chronic hepatitis C virus infection.Effect of inflammation on lacrimal gland function.Ocular manifestations of systemic lupus erythematosus: a clinical review.New pharmacological approaches to the cholinergic system: an overview on muscarinic receptor ligands and cholinesterase inhibitors.Cholinergic receptor pathways involved in apoptosis, cell proliferation and neuronal differentiation.Sjögren's syndrome sufferers have increased oral yeast levels despite regular dental care.
P2860
Q24657833-0A6CDF38-DD9B-428A-A482-6441AE2F6D40Q33394887-A0D4263C-6187-476F-97CB-886720DCAB38Q34338027-B2BA927A-5A50-4558-A149-24382C4154A3Q36398299-C938586A-6A28-4D81-9E9A-C50B30441CB9Q38099889-E0EA6937-8824-486F-BA8C-50EE80A62F2DQ42556634-FA1C1C55-82C3-4BE8-A59B-74D6F221494DQ47886232-A4A10701-7455-4685-A742-2E252AED2AE7
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Sjogren's syndrome: evolving therapies.
@ast
Sjogren's syndrome: evolving therapies.
@en
type
label
Sjogren's syndrome: evolving therapies.
@ast
Sjogren's syndrome: evolving therapies.
@en
prefLabel
Sjogren's syndrome: evolving therapies.
@ast
Sjogren's syndrome: evolving therapies.
@en
P2860
P1476
Sjogren's syndrome: evolving therapies.
@en
P2093
Robert I Fox
P2860
P304
P356
10.1517/13543784.12.2.247
P407
P577
2003-02-01T00:00:00Z